ISRCTN72647928已完成未知
Palmitoylethanolamide intake and systemic endothelial function in ocular hypertensive patients: a single centre, randomized double blind, placebo controlled cross-over study
niversity of Bologna (Italy)0 个研究点目标入组 80 人开始时间: 2011年9月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. 40 patients aged < 65 years (mean 56.8±8.1)
- •2. Baseline IOP >= 22 mm/Hg, on at least two measurements (mean 23.11±0.93)
- •3. Open anterior chamber angle at gonioscopy, cup/disc ratio < 0.4
- •4. Normal visual field (VF) (MD <3 dB and PSD < 2.5 dB) and corneal central thickness within normal values
- •5. 40 healthy control subjects aged matched (mean 56.2±10.4)
排除标准
- •1. Cardiovascular disease
- •2. Diabetes, hypertension, hypercholesterolemia
- •3. Vasoactive medications
研究者
相似试验
已完成
3 期
The effect of Palmitoylethanolamide (PEA) supplementation on the symptoms of allergic rhinitis - A double-blind placebo controlled trial.Allergic rhinitisInflammatory and Immune System - AllergiesACTRN12619001368123RDC Global Pty Ltd162
尚未招募
2 期
Research on Palmitoylethanolamide (PEA) Extract in Healthy PeopleCTRI/2024/02/062402Tilman SA
进行中（未招募）
不适用
europrotective effects of palmitoylethanolamide in diabetic neuropathy: a pilot study. - palmitoylethanolamide (PEA) - diabetic neuropathyMedDRA version: 12.0Level: LLTClassification code 10029331Term: Neuropathy peripheraldiabetic neuropathyEUCTR2009-013643-11-ITISTITUTO NEUROLOGICO CARLO BESTA
已完成
3 期
Evaluation of Oleoylethanolamide supplementation in the prevention and treatment of non-alcoholic fatty liver diseaseon-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20110530006652N2Tabriz University of Medical Sciences74
招募中
3 期
Effect of Palmitoylethanolamide (PEA) and Oleoylethanolamide (OEA) Compared to a Placebo on the Gut Microbiome in an Adult Population – A double blind, randomised controlled trial.Gut microbiomeGut barrier functionGut biochemistryOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonAlternative and Complementary Medicine - Other alternative and complementary medicineMetabolic and Endocrine - Normal metabolism and endocrine development and functionACTRN12621000017820RDC Global Pty Ltd120